SEC 13F Intelligence

Tibra Equities Europe Ltd / ALXN

Tibra Equities Europe Ltd’s Alexion Pharmaceuticals Inc Position

Does Tibra Equities Europe Ltd own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 204.5K shares worth $38M in Q2 2021; the fund’s latest 13F (Q1 2022) no longer reports it.

Position Value
$38M
Q2 2021
Shares
204.5K
% of Portfolio
+11.60%
Quarters Held
5
position exited

Position History ALXN

Reported value by quarter
Q4 ’19: $1MQ4 ’19Q3 ’20: $2MQ3 ’20Q4 ’20: $22MQ4 ’20Q1 ’21: $37MQ1 ’21Q2 ’21: $38MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021204.5K$38M+11.60%
Q1 2021240.6K$37M+11.25%
Q4 2020143.4K$22M+2.29%
Q3 202015.3K$2M+0.37%
Q4 201912.1K$1M+0.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tibra Equities Europe Ltd’s full portfolio or all institutional holders of ALXN.